Forms and Documents
- Molecular confirmation of a clinical diagnosis
- Testing of patients suspected of riboflavin transporter deficiency
- Prenatal diagnosis for known familial mutation(s) in at-risk pregnancies.
*Reporting times are typical, but could be extended in situations outside GeneDx's reasonable control.
**The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
- Jaeger et al. (2016) J. Inherit. Metab. Dis. 39 (4):559-64 (PMID: 26973221)
- Manole A, Houlden H. Riboflavin Transporter Deficiency Neuronopathy. 2015 Jun 11. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
- Olsen et al. (2016) Am. J. Hum. Genet. 98(6):1130-45 (PMID: 27259049)
- Dewulf et al. (2016). Mol. Genet. Metab. 118(3):185-9 (PMID: 27233227)
- Ho et al. (2011). Hum. Mutat. 32(1):E1976-84 (PMID: 21089064)
- Foley et al. (2014) Brain: A Journal Of Neurology 137 (Pt 1):44-56 (PMID: 24253200)
- Schiff et al., (2016) New Eng. J. Med. 374:795-797.